17 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp04855 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Synthetic peptide | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 70 µM |
| dbacp04856 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Synthetic peptide | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 50 µM |
| dbacp04857 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Synthetic peptide | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 50 µM |
| dbacp04858 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Synthetic peptide | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 40 µM |
| dbacp04859 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Residue of 39-65 of porcine NK-lysine | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 4.3±0.3 µM |
| dbacp04860 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Residue of 39-65 of porcine NK-lysine | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 70 µM (approx.) |
| dbacp04861 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Residue of 39-65 of porcine NK-lysine | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 50 µM (approx.) |
| dbacp04862 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Residue of 39-65 of porcine NK-lysine | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 50 µM (approx.) |
| dbacp04863 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | Residue of 39-65 of porcine NK-lysine | Physical membrane disruption | MTT/MTS assay | E42/02 | Skin cancer | IC50 : 40 µM (approx.) |
| dbacp04864 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | NB LA-N-1 | Colorectal cancer | LD50 : 1-4 µM |
| dbacp04865 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | SH-SY5Y | Brain tumor | LD50 : 1-4 µM |
| dbacp04866 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | U-937 | Lymphoma cancer | LD50 : 30 µM |
| dbacp04867 | NK-2 | KILRGVCKKIMRTFLRRISKDILTGKK | NK-lysin | Cell membrane disintegration | PI-uptake assay | SW-480 | Leukemia cancer | LD50 : 1-4 µM |
| dbacp04868 | NK-2 (Mammals, Animals) | KILRGVCKKIMRTFLRRISKDILTGKK | Mammal | Not specified | MTT assay | EJ | Not found | IC50 : 8.4 μM |
| dbacp04869 | NK-2 (Mammals, Animals) | KILRGVCKKIMRTFLRRISKDILTGKK | Mammal | Not specified | MTT assay | PC-3 | Not found | IC50 : 4.1 μM |
| dbacp04870 | NK-2 (Mammals, Animals) | KILRGVCKKIMRTFLRRISKDILTGKK | Mammal | Not specified | MTT assay | T24 | Not found | IC50 : 10.1 μM |
| dbacp04871 | NK-2 (Mammals, Animals) | KILRGVCKKIMRTFLRRISKDILTGKK | Mammal | Not specified | MTT assay | HL-60 | Not found | IC50 : 13.7 μM |